Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats

Behavioural Brain Research

Volumn 120, Issue 1, 2001, Pages 105-110

  Lu, Lin ^a,b   Huang, Mingsheng ^b   Ma, Lan ^a   Li, Jing ^b  

^a FUDAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Antagonist; Cholecystokinin; Opiate dependence; Receptor; Relapse; Subtype

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DEVAZEPIDE; MORPHINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; MORPHINE ADDICTION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; RELAPSE;

ANIMALS; BENZODIAZEPINONES; CONDITIONING (PSYCHOLOGY); DEVAZEPIDE; EXTINCTION, PSYCHOLOGICAL; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MORPHINE DEPENDENCE; PHENYLUREA COMPOUNDS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CHOLECYSTOKININ A; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CHOLECYSTOKININ; RECURRENCE;

EID: 0035826519     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(00)00361-2     Document Type: Article

References (40)

1. Two faces of cholecystokinin: anxiety and schizophrenia
2. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365260, a central cholecystokinin receptor antagonist, in patients with panic disorder
3. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder
4. Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement
5. Microinjections of phencyclidine and related drugs into nucleus accumbens shell potentiate medial forebrain bundle brain stimulation reward
6. The role of cholecystokinin (CCK), CCK-A or CCK-B receptor antagonist in the spontaneous preference for drug of abuse (alcohol or cocaine) in naïve rats
7. Antidepressant-like effects of CCK-B antagonists in mice: antagonism by naltrindole
8. Existence of striatal nerve cells coexpressing CCK-B and D2 receptor mRNAs
9. Antidepresant-like effects of CCK-B receptor antagonists: involvement of the opioid system
10. Morphine place conditioning is differentially affected by CCK-A and CCK-B receptor antagonists
11. Blockade of morphine place conditioning by the CCK-A receptor antagonist devazepide
12. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK antagonists
13. Differential gene expression of CCK-A and CCK-B receptor in the rat brain
14. Functional and molecular characterization of CCK receptors in the rat pancreatic acinar cell line AR4-2J
15. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats
16. Forced swimming and glucocorticoids facilitate the reactivation of morphine conditioned place preference induced by stress in adrenalectomized rats
17. Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and CCK-B antagonist PD-134308
18. From motivation to action: function interface between the limbic system and the motor system
19. Structure of porcine cholecystokinin-pancreozymin
20. G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo
21. 8
22. CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology
23. Endogenous opiate
24. 8
25. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
26. Cholecystikinin-like material and CCK mRNA levels in the rat brain and spinal cord after acute or repeated morphine treatment
27. NMDA receptors in the nucleus accumbens modulate intravenous cocaine but not heroin self-administration in the rat
28. The molecular nature of vascularly released cholecystokinin from the isolated perfused porcine duodenum
29. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry
30. On the mechanism of cholecystokinin: receptor stimulation attenuates morphine dependence in mice
31. Association of enkephalin catobolism inhibitors and CCK-B antagonists: a potential use in the management of pain and opioid addiction
32. Opposite role of CCK-A and CCK-B receptors in the modulation of endogenous enkephalin antidepressant-like effects
33. Cholecystokinin and morphine analgesia
34. Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward
35. Antagonism of cholecystokinin function in the rostral and caudal nucleus accumbens: differential effects on brain stimulation reward
36. Week tolerance to the antinociceptive effect induced by the association of a peptidase inhibitor and a CCK-B antagonist
37. The attenuation of morphine-conditioned place preference following chronic mild stress is reversed by a CCK-B receptor antagonist
38. Choleycystokinin in mammalian primary sensory neurons and spinal cord: in situ hybridization studies on rat and monkey spinal ganglia
39. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat
40. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats